Related Experiment Video

Updated: May 23, 2026

Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay
12:26

Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay

Published on: May 3, 2018

Chemical-genetic analysis of cyclin dependent kinase 2 function reveals an important role in cellular transformation

Dai Horiuchi1, Noelle E Huskey, Leonard Kusdra

  • 1Department of Medicine, University of California, San Francisco, CA 94143, USA.

Proceedings of the National Academy of Sciences of the United States of America
|April 5, 2012
PubMed

Insights

Cyclin-dependent kinase 2 (CDK2) activity is crucial for cell cycle progression and proliferation. Chemical inhibition of CDK2, unlike genetic knockdown, reveals its essential role in normal and cancer cells, suggesting therapeutic potential.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Cancer Research

Background:

  • Cyclin-dependent kinases (CDKs) are serine/threonine kinases regulating mammalian cell cycle progression.
  • CDK2 has been implicated in S-phase entry and progression, with elevated activity observed in human tumors.
  • Previous genetic studies (KO/knockdown) yielded conflicting results regarding CDK2's necessity for proliferation.

Purpose of the Study:

  • To investigate the role of CDK2 kinase activity in cell proliferation using a chemical-genetic approach.
  • To compare the effects of small-molecule CDK2 inhibition with siRNA-mediated knockdown.
  • To assess CDK2's necessity for normal cell cycle progression and cancer cell growth.

Main Methods:

  • Employed a chemical-genetic strategy for specific inhibition of CDK2 kinase activity.
  • Directly compared small-molecule inhibition with siRNA knockdown of CDK2.
  • Assessed cellular proliferation in nontransformed cells and anchorage-independent growth in cancer cells.

Main Results:

  • Small-molecule inhibition of CDK2 caused significant proliferation defects in normal cells, contrasting with siRNA knockdown.
  • CDK2 inhibition markedly reduced anchorage-independent growth of human cancer cells and oncogene-transformed cells.
  • Demonstrated a discrepancy between inhibiting CDK2 activity and reducing CDK2 protein levels.

Conclusions:

  • CDK2 kinase activity is essential for normal mammalian cell cycle progression.
  • Chemical inhibition of CDK2 effectively impairs cancer cell growth, highlighting its functional importance.
  • CDK2 represents a potential therapeutic target for cancer treatment.

More Related Videos

Identification of Novel CK2 Kinase Substrates Using a Versatile Biochemical Approach11:11

Identification of Novel CK2 Kinase Substrates Using a Versatile Biochemical Approach

Published on: February 21, 2019

Experimental Approaches to Study Mitochondrial Localization and Function of a Nuclear Cell Cycle Kinase, Cdk113:15

Experimental Approaches to Study Mitochondrial Localization and Function of a Nuclear Cell Cycle Kinase, Cdk1

Published on: February 25, 2016

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
Positive Regulator Molecules01:45

Positive Regulator Molecules

To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.